Award
National Cancer Institute 5R01CA285967-02
Targeting heat shock factor 1 (HSF1) to increase tumor infiltrating lymphocytes in metastatic breast cancer.
Recipient
Indiana University Indianapolis
Award Amount
$375,964.00
Ceiling
$375,964.00
Awarded
April 27, 2026
Identifier
5R01CA285967-02
Research project awarded by the National Cancer Institute to study HSF1's role in metastatic breast cancer immunotherapy, aiming to increase tumor infiltrating lymphocytes.
Description
This is a research project funded by the NIH/NCI focusing on immunotherapy and molecular mechanisms in metastatic breast cancer. The project involves multiple aims including studying the role of HSF1 in immune cell recruitment, assessing the efficacy of HSF1 inhibition, and understanding myeloid cell populations. The project is based at Indiana University Indianapolis.